IVF is more cost-effective than intra-uterine insemination, mathematical model predicts

In a study published today in the open access journal BMC Health Services Research, researchers use a mathematical model to show that offering a full cycle of in-vitro fertilisation (IVF) is better value for money for couples and tax-payers than offering multiple cycles of intra-uterine insemination (IUI), followed by IVF if IUI fails. IUI is the treatment currently recommended by the UK National Institute for Clinical Excellence (NICE) for unexplained infertility and male factor subfertility. Although it is cheaper than IVF, IUI requires many more attempts and often fails to result in pregnancy, forcing couples to undergo an IVF cycle after many attempts at IUI.

Nora Pashayan from the Institute of Public Health in Cambridge, UK, collaborated with colleagues to build a mathematical model that evaluates the cost-effectiveness of IVF and that of IUI, followed by IVF if IUI fails. They evaluated the cost of treatment for 100 simulated couples with unexplained infertility and mild male factor subfertility.

Pashayan et al.’s results show that, as IVF is more efficient and more likely to result in pregnancy after the first trial, offering IVF first is more cost-effective than offering IUI alone, or than offering IUI followed by IVF if IUI fails. The amount of money saved if IVF were offered first instead of unstimulated IUI, the least expensive of IUI treatments, would amount to £174,200. This amount of money could pay for IVF treatments for an additional 54 couples.

Media Contact

Juliette Savin alfa

More Information:

http://www.biomedcentral.com

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Lower dose of mpox vaccine is safe

… and generates six-week antibody response equivalent to standard regimen. Study highlights need for defined markers of mpox immunity to inform public health use. A dose-sparing intradermal mpox vaccination regimen…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

Partners & Sponsors